Correlation Between Tff Pharmaceuticals and Avenue Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tff Pharmaceuticals and Avenue Therapeutics, you can compare the effects of market volatilities on Tff Pharmaceuticals and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Avenue Therapeutics.

Diversification Opportunities for Tff Pharmaceuticals and Avenue Therapeutics

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Tff and Avenue is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Avenue Therapeutics go up and down completely randomly.

Pair Corralation between Tff Pharmaceuticals and Avenue Therapeutics

Given the investment horizon of 90 days Tff Pharmaceuticals is expected to under-perform the Avenue Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Tff Pharmaceuticals is 1.0 times less risky than Avenue Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Avenue Therapeutics is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  7,613  in Avenue Therapeutics on August 31, 2024 and sell it today you would lose (7,407) from holding Avenue Therapeutics or give up 97.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Tff Pharmaceuticals  vs.  Avenue Therapeutics

 Performance 
       Timeline  
Tff Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tff Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Avenue Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avenue Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Tff Pharmaceuticals and Avenue Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tff Pharmaceuticals and Avenue Therapeutics

The main advantage of trading using opposite Tff Pharmaceuticals and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.
The idea behind Tff Pharmaceuticals and Avenue Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data